Gland Pharma Board Approves Unaudited Financial Results for Q1 FY27

Gland Pharma Limited announced that its Board of Directors, in a meeting held on August 10, 2026, has approved the Unaudited Financial Results (standalone and consolidated) for the quarter ended June 30, 2026. These results have been reviewed and recommended by the Audit Committee and prepared in compliance with Indian Accounting Standards (Ind AS). The company also submitted the Limited Review Report(s) and a press release with an investor presentation. The board meeting commenced at 15:00 IST and concluded at 16:05 IST.